Hara Y, Kono A, Tanaka M
Gan To Kagaku Ryoho. 1984 Oct;11(10):2261-6.
The authors have made clear that 5'-deoxy-5-fluorouridine (5'-DFUR), a derivative of 5-fluorouracil (5-FU), is activated by thymidine phosphorylase with has a particularly high activity in human malignant tumors. This derivative therefore, has fewer side-effects and can be expected to produce a greater antitumor effect when administered to cancer patients. Blood levels of 5'-DFUR and 5-FU were then observed with time after oral or intravenous 5'-DFUR administration in order to study its clinical effect. First, a method for measurement of 5'-DFUR and 5-FU was devised using high-performance liquid chromatography (HPLC). The results obtained using this method revealed that for intravenous administration both 5'-DFUR and 5-FU showed rapid drops in blood level while for oral administration both showed blood level peaks after one hour which were maintained of the same level for two hours, decreasing gradually thereafter. 5-FU showed a blood level peak after one hour, decreasing gradually thereafter. From the above results it was proved that a relatively high percentage of orally administered 5'-DFUR was absorbed from the intestine.
作者已经明确指出,5'-脱氧-5-氟尿苷(5'-DFUR)作为5-氟尿嘧啶(5-FU)的衍生物,可被胸苷磷酸化酶激活,而胸苷磷酸化酶在人类恶性肿瘤中具有特别高的活性。因此,这种衍生物副作用较少,预计给癌症患者使用时会产生更大的抗肿瘤效果。为了研究其临床效果,在口服或静脉注射5'-DFUR后,随时间观察了5'-DFUR和5-FU的血药浓度。首先,采用高效液相色谱法(HPLC)设计了一种测定5'-DFUR和5-FU的方法。使用该方法获得的结果表明,静脉注射时,5'-DFUR和5-FU的血药浓度均迅速下降;口服时,两者在一小时后均出现血药浓度峰值,并在两小时内保持在同一水平,此后逐渐下降。5-FU在一小时后出现血药浓度峰值,此后逐渐下降。从上述结果证明,口服的5'-DFUR有较高比例从肠道吸收。